Dorry L Segev

InstitutionJohns Hopkins University School of Medicine
AddressBaltimore
Maryland
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 45 Covid-19 publications, with a maximum of 5 publications in May 2021
    All Publications
    Bar chart showing 304 publications over 20 distinct years, with a maximum of 39 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Permpalung N, Chiang TP, Massie AB, Zhang SX, Avery RK, Nematollahi S, Ostrander D, Segev DL, Marr KA. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients. Clin Infect Dis. 2022 01 07; 74(1):83-91. PMID: 33693551.
      Citations: 18     Fields:    Translation:Humans
    2. Connolly CM, Ruddy JA, Boyarsky BJ, Barbur I, Werbel WA, Geetha D, Garonzik-Wang JM, Segev DL, Christopher-Stine L, Paik JJ. Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination. Arthritis Rheumatol. 2022 01; 74(1):28-32. PMID: 34346185.
      Citations: 1     Fields:    Translation:Humans
    3. Alejo JL, Mitchell J, Chiang TP, Abedon AT, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2021 12 01; 105(12):e280-e281. PMID: 34428188.
      Citations: 6     Fields:    Translation:Humans
    4. Ruddy JA, Boyarsky BJ, Bailey JR, Karaba AH, Garonzik-Wang JM, Segev DL, Durand CM, Werbel WA. Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV. AIDS. 2021 11 15; 35(14):2399-2401. PMID: 34261097.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    5. Boyarsky BJ, Barbur I, Chiang TP, Ou MT, Greenberg RS, Teles AT, Krach MR, López JI, Garonzik-Wang JM, Avery RK, Massie AB, Segev DL, Werbel WA. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271. PMID: 34284420.
      Citations: 3     Fields:    Translation:Humans
    6. Qin CX, Moore LW, Anjan S, Rahamimov R, Sifri CD, Ali NM, Morales MK, Tsapepas DS, Basic-Jukic N, Miller RA, van Duin D, Santella RN, Wadei HM, Shah PD, Gage N, Malinis M, Aslam S, Todesco E, Werbel WA, Avery RK, Segev DL. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients. Transplantation. 2021 11 01; 105(11):e265-e266. PMID: 34310531.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    7. Ou MT, Boyarsky BJ, Motter JD, Greenberg RS, Teles AT, Ruddy JA, Krach MR, Jain VS, Werbel WA, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):2170-2174. PMID: 33859151.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    8. Boyarsky BJ, Chiang TP, Teles AT, Greenberg RS, Krach MR, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL, Werbel AWA. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138. PMID: 34241987.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    9. Strauss AT, Hallett AM, Boyarsky BJ, Ou MT, Werbel WA, Avery RK, Tobian AAR, Massie AB, Hamilton JPA, Garonzik-Wang JM, Segev DL. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856. PMID: 34407309.
      Citations: 3     Fields:    Translation:Humans
    10. Ruddy JA, Boyarsky BJ, Werbel WA, Bailey JR, Karaba AH, Garonzik-Wang JM, Segev DL, Durand CM. Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV. AIDS. 2021 09 01; 35(11):1872-1874. PMID: 33993131.
      Citations: 5     Fields:    Translation:Humans
    11. Ou MT, Boyarsky BJ, Chiang TPY, Bae S, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123. PMID: 34028386.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    12. Ali NM, Alnazari N, Mehta SA, Boyarsky B, Avery RK, Segev DL, Montgomery RA, Stewart ZA. Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination. Transplantation. 2021 09 01; 105(9):e104-e106. PMID: 34049360.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    13. Chiang TP, Connolly CM, Ruddy JA, Boyarsky BJ, Alejo JL, Werbel WA, Massie A, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1365-1366. PMID: 34429320.
      Citations: 2     Fields:    Translation:Humans
    14. Hallett AM, Greenberg RS, Boyarsky BJ, Shah PD, Ou MT, Teles AT, Krach MR, López JI, Werbel WA, Avery RK, Bae S, Tobian AA, Massie AB, Higgins RSD, Garonzik-Wang JM, Segev DL, Bush EL. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021 12; 40(12):1579-1588. PMID: 34456108.
      Citations: 2     Fields:    Translation:Humans
    15. Boyarsky BJ, Chiang TP, Ou MT, Werbel WA, Massie AB, Segev DL, Garonzik-Wang JM. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021 08 01; 105(8):e82-e83. PMID: 34098566.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    16. Stock PG, Henrich TJ, Segev DL, Werbel WA. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest. 2021 07 15; 131(14). PMID: 34143755.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    17. Heeger PS, Larsen CP, Segev DL. Implications of defective immune responses in SARS-CoV-2 vaccinated organ transplant recipients. Sci Immunol. 2021 07 01; 6(61). PMID: 34210786.
      Citations: 1     Fields:    Translation:Humans
    18. Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 09; 174(9):1330-1332. PMID: 34125572.
      Citations: 52     Fields:    Translation:Humans
    19. Sandal S, Boyarsky BJ, Massie A, Chiang TP, Segev DL, Cantarovich M. Immunosuppression practices during the COVID-19 pandemic: A multinational survey study of transplant programs. Clin Transplant. 2021 08; 35(8):e14376. PMID: 34050961.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    20. Ou MT, Boyarsky BJ, Zeiser LB, Po-Yu Chiang T, Ruddy J, Van Pilsum Rasmussen SE, Martin J, St Clair Russell J, Durand CM, Avery RK, Werbel WA, Cooper M, Massie AB, Segev DL, Garonzik-Wang JM. Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine. Transplant Direct. 2021 Jul; 7(7):e713. PMID: 34131585.
      Citations: 3     
    21. Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 06 01; 325(21):2204-2206. PMID: 33950155.
      Citations: 128     Fields:    Translation:Humans
    22. Connolly CM, Boyarsky BJ, Ruddy JA, Werbel WA, Christopher-Stine L, Garonzik-Wang JM, Segev DL, Paik JJ. Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series. Ann Intern Med. 2021 09; 174(9):1332-1334. PMID: 34029488.
      Citations: 6     Fields:    Translation:Humans
    23. Ruddy JA, Connolly CM, Boyarsky BJ, Werbel WA, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ. High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1351-1352. PMID: 34031032.
      Citations: 16     Fields:    Translation:Humans
    24. Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021 05 04; 325(17):1784-1786. PMID: 33720292.
      Citations: 109     Fields:    Translation:Humans
    25. Boyarsky BJ, Ou MT, Greenberg RS, Teles AT, Werbel WA, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 05 01; 105(5):e56-e57. PMID: 33560728.
      Citations: 14     Fields:    Translation:Humans
    26. Boyarsky BJ, Ou MT, Werbel WA, Avery RK, Clarke WA, Tobian AAR, Massie AB, Segev DL, Garonzik Wang JM. Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study. Transplantation. 2021 05 01; 105(5):e52-e53. PMID: 33617174.
      Citations: 3     Fields:    Translation:Humans
    27. Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM, Segev DL, Paik JJ. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 Mar 23. PMID: 33757968.
      Citations: 31     Fields:    
    28. Connolly CM, Ruddy JA, Boyarsky BJ, Avery RK, Werbel WA, Segev DL, Garonzik-Wang J, Paik JJ. Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 Mar 19. PMID: 33741555.
      Citations: 12     Fields:    
    29. Avery RK, Chiang TP, Marr KA, Garonzik-Wang J, Segev DL, Massie AB. Response to "COVID-19 in SOT versus non-SOT". Am J Transplant. 2021 06; 21(6):2306. PMID: 33560556.
      Citations:    Fields:    Translation:Humans
    30. Avery RK, Chiang TP, Marr KA, Brennan DC, Sait AS, Garibaldi BT, Shah P, Ostrander D, Steinke SM, Permpalung N, Cochran W, Makary MA, Garonzik-Wang J, Segev DL, Massie AB. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort. Am J Transplant. 2021 07; 21(7):2498-2508. PMID: 33284498.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    31. Bae S, McAdams-DeMarco MA, Massie AB, Ahn JB, Werbel WA, Brennan DC, Lentine KL, Durand CM, Segev DL. Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic. Transplantation. 2021 01 01; 105(1):170-176. PMID: 33093404.
      Citations: 5     Fields:    Translation:Humans
    32. Mehta SA, Rana MM, Motter JD, Small CB, Pereira MR, Stosor V, Elias N, Haydel B, Florman S, Odim J, Morsheimer M, Robien M, Massie AB, Brown D, Boyarsky BJ, Garonzik-Wang J, Tobian AAR, Werbel WA, Segev DL, Durand CM. Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. Transplantation. 2021 01 01; 105(1):216-224. PMID: 33165238.
      Citations: 6     Fields:    Translation:Humans
    33. Lentine KL, Lam NN, Caliskan Y, Alhamad T, Xiao H, Schnitzler MA, Chang SH, Axelrod D, Segev DL, McAdams-DeMarco M, Kasiske BL, Hess GP, Brennan DC. Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data. Clin Transplant. 2020 12; 34(12):e14118. PMID: 33048372.
      Citations: 1     Fields:    Translation:Humans
    34. Strauss AT, Boyarsky BJ, Garonzik-Wang JM, Werbel W, Durand CM, Avery RK, Jackson KR, Kernodle AB, Baker T, Snyder J, Segev DL, Massie AB. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Am J Transplant. 2021 05; 21(5):1838-1847. PMID: 33107180.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    35. Al Ammary F, Sidoti C, Segev DL, Henderson ML. Health Care Policy and Regulatory Challenges for Adoption of Telemedicine in Kidney Transplantation. Am J Kidney Dis. 2021 05; 77(5):773-776. PMID: 33171215.
      Citations:    Fields:    Translation:Humans
    36. Boyarsky BJ, Ruck JM, Chiang TP, Werbel WA, Strauss AT, Getsin SN, Jackson KR, Kernodle AB, Van Pilsum Rasmussen SE, Baker TB, Al Ammary F, Durand CM, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM. Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States. Clin Transplant. 2020 12; 34(12):e14086. PMID: 32918766.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    37. Strauss AT, Cartier D, Gunning BA, Boyarsky BJ, Snyder J, Segev DL, Roush M, Massie AB. Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community. Am J Transplant. 2020 11; 20(11):3123-3130. PMID: 32860307.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    38. Charnaya O, Chiang TP, Wang R, Motter JD, Boyarsky BJ, King EA, Werbel WA, Durand CM, Avery RK, Segev DL, Massie AB, Garonzik-Wang JM. Effects of COVID-19 pandemic on pediatric kidney transplant in the United States. Pediatr Nephrol. 2021 01; 36(1):143-151. PMID: 32980942.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    39. Boyarsky BJ, Werbel WA, Durand CM, Avery RK, Jackson KR, Kernodle AB, Snyder J, Hirose R, Massie IM, Garonzik-Wang JM, Segev DL, Massie AB. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020 11; 20(11):3131-3139. PMID: 32594606.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    40. Abuzeineh M, Muzaale AD, Crews DC, Avery RK, Brotman DJ, Brennan DC, Segev DL, Al Ammary F. Telemedicine in the Care of Kidney Transplant Recipients With Coronavirus Disease 2019: Case Reports. Transplant Proc. 2020 Nov; 52(9):2620-2625. PMID: 32798002.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    41. Massie AB, Boyarsky BJ, Werbel WA, Bae S, Chow EKH, Avery RK, Durand CM, Desai N, Brennan D, Garonzik-Wang JM, Segev DL. Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study. Am J Transplant. 2020 11; 20(11):2997-3007. PMID: 32515544.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    42. Boyarsky BJ, Massie AB, Love AD, Werbel WA, Durand CM, Avery RK, Jackson KR, Kernodle AB, Thomas AG, Ronin M, Altrich M, Niles P, Trahan C, Hewlett J, Segev DL, Garonzik-Wang JM. Early Experiences With COVID-19 Testing in Transplantation. Transplant Direct. 2020 Jul; 6(7):e572. PMID: 32766427.
      Citations: 1     
    43. Boyarsky BJ, Po-Yu Chiang T, Werbel WA, Durand CM, Avery RK, Getsin SN, Jackson KR, Kernodle AB, Van Pilsum Rasmussen SE, Massie AB, Segev DL, Garonzik-Wang JM. Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. 2020 07; 20(7):1809-1818. PMID: 32282982.
      Citations: 72     Fields:    Translation:HumansCellsPHPublic Health
    Segev's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (345)
    Explore
    _
    Co-Authors (139)
    Explore
    _
    Similar People (60)
    Explore
    _